EU Pharmaceutical Law Forum 2012

This conference provides an unrivalled opportunity for legal professionals working in private practice and in-house counsel to get a complete round-up of the most important legal decisions made over the past 12 months.

This meeting is Europe’s most respected pharmaceutical law conference and has gained a solid reputation for covering the most important topics and attracting THE VERY BEST SPEAKERS.

Benefits of Attending in 2012:

-Hear critical feedback from the EU Commission

on competition law in the pharmaceutical industry, the European patent system and the revision of the EU regulatory framework for medical devices.

-Understand the recent trends in pricing and reimbursement

in both the pharmaceutical and medical device industries and learn how Health Technology Assessments are working in practice.

-Examine reverse patent settlements

and the European Commission proceedings with this year’s high profile cases. Identify the nature of patent disputes, decide if they can be settled and learn how to manage your risk.

-Assess the key regulatory frameworks, challenges and opportunities

with orphan medicinal products, biosimilars and clinical trials with real life insight from Pfizer, Bristows and Covington and Burling.

-Focus on advertising and social media

in the pharmaceutical and medical device industries during our interactive evening seminar. Learn how to use media appropriately to promote your products with Novartis, the EMA and the PMCPA.